62
Views
5
CrossRef citations to date
0
Altmetric
Original Research

A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery

, , , , &
Pages 1243-1255 | Published online: 24 Mar 2016

References

  • GomaaAIWakedIRecent advances in multidisciplinary management of hepatocellular carcinomaWorld J Hepatol20157467368725866604
  • CallegariEGramantieriLDomenicaliMD’AbundoLSabbioniSNegriniMMicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approachesCell Death Differ2015221465725190143
  • ColagrandeSReginiFTalianiGGNardiCInghilesiALAdvanced hepatocellular carcinoma and sorafenib: diagnosis, indications, clinical and radiological follow-upWorld J Hepatol2015781041105326052393
  • KulikLMChokechanachaisakulAEvaluation and management of hepatocellular carcinomaClin Liver Dis2015191234325454295
  • BredtLCMierzwaTCRachidAFFernandesFGZaniniJCSurgery for early stage hepatocellular carcinomaInt J Hepatobiliary Pancreat Dis2015514755
  • WangPSongWLiHAssociation between donor and recipient smoothened gene polymorphisms and the risk of hepatocellular carcinoma recurrence following orthotopic liver transplantation in a Han Chinese populationTumour Biol201536107807781525944162
  • MadkhaliAAFadelZTAljiffryMMHassanainMMSurgical treatment for hepatocellular carcinomaSaudi J Gastroenterol2015211111725672233
  • BruixJShermanMManagement of hepatocellular carcinomaHepatology20054251208123616250051
  • LoCMNganHTsoWKRandomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinomaHepatology20023551164117111981766
  • PoonRTFanSTLoCMLiuCLWongJIntrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factorsAnn Surg1999229221622210024103
  • MoensSGoveiaJStaporPCCantelmoARCarmelietPThe multifaceted activity of VEGF in angiogenesis – Implications for therapy responsesCytokine Growth Factor Rev201425447348225169850
  • CammàCSchepisFOrlandoATransarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trialsRadiology20022241475412091661
  • WuHPFengGSLiangHMZhengCSLiXVascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in ratsWorld J Gastroenterol200410681381815040023
  • MutoJShirabeKSugimachiKMaeharaYReview of angiogenesis in hepatocellular carcinomaHepatol Res20154511924533487
  • SergioACristoforiCCardinRTranscatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasivenessAm J Gastroenterol2008103491492118177453
  • Carrillo de Santa PauEAriasFCCaso PeláezEPrognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancerCancer200911581701171219197998
  • MohammedRAGreenAEl-ShikhSPaishECEllisIOMartinSGPrognostic significance of vascular endothelial cell growth factors-A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesisBr J Cancer20079671092110017353919
  • MylonaEAlexandrouPMpakaliAClinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinomaEur J Surg Oncol200733329430017129704
  • RibasCColleoniGWSilvaMRCarregozaMJBordinJOPrognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myelomaEur J Haematol200473531131715458509
  • FerraraNVEGF and the quest for tumour angiogenesis factorsNat Rev Cancer200221079580312360282
  • KupesicSKurjakAContrast-enhanced, three-dimensional power Doppler sonography for differentiation of adnexal massesObstet Gynecol200096345245810960641
  • SemelaDDufourJFAngiogenesis and hepatocellular carcinomaJ Hepatol200441586488015519663
  • BernsteinECaudyAAHammondSMHannonGJRole for a bidentate ribonuclease in the initiation step of RNA interferenceNature2001409681836336611201747
  • ElbashirSMHarborthJLendeckelWYalcinAWeberKTuschlTDuplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cellsNature2001411683649449811373684
  • TeplovaMFaraziTATuschlTPatelDJStructural basis underlying CAC RNA recognition by the RRM domain of dimeric RNA-binding protein RBPMSQ Rev Biophys2015811126347403
  • LiuKChenHYouQShiHWangZThe siRNA cocktail targeting VEGF and HER2 inhibition on the proliferation and induced apoptosis of gastric cancer cellMol Cell Biochem20143861–211712424158524
  • SunPYuHZhangWQHuMLvRLentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivoOncol Rep20122851687169222895814
  • TaoJTuYTHuangCZInhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approachBr J Dermatol2005153471572416181451
  • RaskopfEVogtASauerbruchTSchmitzVsiRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivoJ Hepatol200849697798418845354
  • MedarovaZPhamWFarrarCPetkovaVMooreAIn vivo imaging of siRNA delivery and silencing in tumorsNat Med200713337237717322898
  • TakeshitaFHokaiwadoNHonmaKBanasAOchiyaTLocal and systemic delivery of siRNAs for oligonucleotide therapyMethods Mol Biol2009487839219301643
  • Gonzalez-GonzalezERaHHickersonRPsiRNA silencing of keratinocyte-specific GFP expression in a transgenic mouse skin modelGene Ther200916896397219474811
  • SongHJChengJYHuSLZhangGYFuYZhangYJValue of 18F-FDG PET/CT in detecting viable tumour and predicting prognosis of hepatocellular carcinoma after TACEClin Radiol201570212813725459673
  • JinWHanHZhouSWangYDongTZhaoCTherapeutic efficacy of brucea javanica oil emulsion (BJOE) combined with transcatheter hepatic arterial chemoembolization (TACE) in patients with primary liver cancerInt J Clin Exp Med2015810189541896226770520
  • MarshallWSKaiserRJRecent advances in the high-speed solid phase synthesis of RNACurr Opin Chem Biol20048322222915183319
  • FuCYXiaRLZhangTFHemokinin-1 (4–11)-induced analgesia selectively up-regulates δ-opioid receptor expression in micePLoS One201492e9044624587368
  • XiaRLFuCYZhangSFJinYTZhaoFKStudy on the distribution sites and the molecular mechanism of analgesia after intracerebroventricular injection of rat/mouse hemokinin-1 in micePeptides20134311312023470255
  • ZhuLNFuCYZhangSFChenWJinYTZhaoFKNovel cytotoxic exhibition mode of antimicrobial peptide anoplin in MEL cells, the cell line of murine Friend leukemia virus – induced leukemic cellsJ Pept Sci201319956657423873700
  • OkadaMKudoSMiyazakiOAntitumoral efficacy and pharmacokinetic properties of pirarubicin upon hepatic intra-arterial injection in the rabbit VX 2 tumour modelBr J Cancer19957135185247880733
  • YoonCJChungJWParkJHTranscatheter arterial chemoembolization with paclitaxel-lipiodol solution in rabbit VX2 liver tumorRadiology2003229112613112944599
  • ZouYZhangMWangQShangDWangLYuGQuantitative investigation of solitary pulmonary nodules: dynamic contrast-enhanced MRI and histopathologic analysisAJR Am J Roentgenol2008191125225918562755
  • LiSDChenYCHackettMJHuangLTumor-targeted delivery of siRNA by self-assembled nanoparticlesMol Ther200816116316917923843
  • Schulze-BergkamenHFleischerBSchuchmannMSuppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis inductionBMC Cancer2006623217014711
  • RibattiDVaccaANicoBSansonnoDDammaccoFAngiogenesis and anti-angiogenesis in hepatocellular carcinomaCancer Treat Rev200632643744416870349
  • DorsettYTuschlTsiRNAs: applications in functional genomics and potential as therapeuticsNat Rev Drug Discov20043431832915060527
  • YanCQZhaoYPThe significance of VEGF siRNA and bFGF siRNA in invasion and proliferation of pancreatic carcinoma cellZhonghua Wai Ke Za Zhi201048861061420646480
  • LeeTHSengSSekineMVascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1PLoS Med200746e18617550303
  • DeezagiAAnsari-MajdSVaseli-HaghNInduced apoptosis in human prostate cancer cells by blocking of vascular endothelial growth factor by siRNAClin Transl Oncol2012141079179922855159
  • BrianeDSlimaniHTagounitsAInhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA deliveryJ Drug Target201220434735422475204
  • BarrMPGraySGGatelyKVascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancerMol Cancer2015144525889301
  • BruixJTreatment of hepatocellular carcinomaHepatology19972522592629021931
  • TrinchetJCBeaugrandMTreatment of hepatocellular carcinoma in patients with cirrhosisJ Hepatol19972747567659365054
  • BruixJLlovetJMCastellsATransarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institutionHepatology1998276157815839620330
  • JeongJMKimYJLeeYSLipiodol solution of a lipophilic agent, 188 Re-TDD, for the treatment of liver cancerNucl Med Biol200128219720411295430
  • GeschwindJFArtemovDAbrahamSChemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysisJ Vasc Interv Radiol200011101245125511099235
  • SimundicAMEducation in clinical chemistry and laboratory medicine in various European countriesBiochem Med (Zagreb)2011211622141198
  • LimdiJKHydeGMEvaluation of abnormal liver function testsPostgrad Med J20037993230731212840117